GSGozde Erkanli Senturk

Gozde Erkanli Senturk

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gozde Erkanli Senturk has a total of 37 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Blood Biomarker Tenascin-C for Detection of Radiation Cardiotoxicity: An Animal Model

    by Ecem Demir, Karolin Yanar, Pınar Atukeren, Serbay Ozkan, Gözde Erkanlı Şentürk, Melike Ülker, Şefika Arzu Ergen, Songül Karaçam, Fazilet Öner Dinçbaş

    Purpose: The aim of this study was to test the hypothesis that Tenascin-C (TNC) levels increase following thoracic radiotherapy (RT), and that elevated serum TNC levels are associated with corresponding increases in myocardial TNC expression in histopathological specimens, supporting its role as a potential biomarker of radiation-induced cardiotoxicity. Methods: Blood and cardiac tissue samples from rats 8 weeks after thoracic radiotherapy were analyzed to evaluate changes in serum TNC levels and myocardial TNC expression, and their association with radiation exposure. Male Wistar rats were randomized to a single 12-Gy dose of mediastinal irradiation or sham irradiation. Serum TNC levels were assessed with rat ELISA kits. Myocardial TNC expression was assessed using immunohistochemistry, and staining intensity was semi-quantitatively graded by blinded observers. Results: Serum Tenascin-C (TNC) levels were elevated in RT only group compared to control (p < 0.001), paralleled by a marked increase in myocardial TNC expression (p < 0.001). A consistent concordance between circulating and tissue-level TNC was observed, supporting its potential as a biomarker of radiation-induced cardiac injury. Conclusions: Significant associations were observed between radiation exposure and both serum Tenascin-C levels and myocardial Tenascin-C expression, demonstrating a concordance between circulating and tissue findings and supporting Tenascin-C as a promising biomarker of radiation-induced cardiotoxicity.

  • Open Access

    Protective Effects of Oxytocin on Experimental Colitis: Modulation of Cytokines, Oxidative Stress, and Caspase-3 Activity

    by Burcu Aydinli Kazalak, Sibel Yaman, Mehmet Faik Ozcelik, Gozde Erkanli Senturk, Rahime Aydinli, Belisa Kaleci, Hafize Uzun

    Background and Objectives: This study investigated the effects of oxytocin (OT) in a 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced colitis model in rats, focusing on its potential anti-inflammatory, antioxidant, and anti-apoptotic properties. Materials and Methods: Forty male Wistar albino rats were randomly assigned to five groups (n = 8): control (intrarectal saline), TNBS-induced colitis, dexamethasone-treated colitis (1 mg/kg, i.p.), and two OT-treated colitis groups (0.5 and 1 mg/kg, i.p.). Body weight changes were recorded over 72 h. Macroscopic and histopathological evaluations were performed following laparotomy and colectomy. Serum and colon tissue samples were analyzed for TNF-α, IL-1β, IL-6, MPO, MDA, GSH, GPx, SOD, and CAT levels. Immunohistochemical analysis of caspase-3 and oxytocin receptor (OTR), as well as immunofluorescence-based OTR expression, were assessed. Results: OT treatment significantly improved macroscopic and histopathological findings compared with the colitis group (p < 0.01). Tissue TNF-α and MDA levels were reduced, while antioxidant parameters were generally improved in OT-treated groups. Caspase-3 immunoreactivity decreased, indicating reduced apoptosis. Although some changes were observed in IL-6 levels, these were not consistent across all comparisons. OTR immunoreactivity appeared reduced in colitis and partially restored following OT administration. Conclusions: OT attenuates experimental colitis by modulating inflammation, oxidative stress, and apoptosis, and may contribute to mucosal healing. These findings suggest that OT has potential as a supportive therapeutic agent in inflammatory bowel disease; however, further studies are required to clarify its mechanisms of action.

  • Oxytocin receptor expression in developing mouse gonads and its modulation by high-dose folic acid

    by Hakan Sahin, Fidan Pashayeva, Gozde Erkanli Senturk

    The oxytocin receptor (OTR) is known to be expressed in various organs, including the adult reproductive system. However, its expression in developing gonads has not yet been reported. This study investigates OTR expression in the ovaries and testes during critical developmental stages, specifically embryonic day 13.5 (E13.5), embryonic day 18.5 (E18.5), and postnatal day 14 (P14). According to our findings, both developing ovaries and testes exhibited OTR expression, including in immature follicle and Sertoli cells. OTR-expressing cells increased in the developing ovary, while a decrease was observed in the postnatal testis. In addition, our results showed that a high dose folic acid (FA) diet affected the number of OTR-expressing cells in developing gonads, particularly during the later stages of embryogenesis. These findings suggest that OTR may play a role in gonadal development and that its expression is influenced by sex. Furthermore, changes in folic acid supplementation may interfere with this developmental process.

  • Open Access

    Liraglutide Enhances Cell Viability and Reduces Oxidative Stress in Hyperglycemic H9c2 Cardiomyocytes

    by Sinem Durmus, Zeki Dogan, Dilek Duzgun Ergun, Mahmut Ozdemir, Hakan Sahin, Gozde Erkanli Senturk, Remise Gelisgen, Hafize Uzun

    Background and Objectives: Cardiovascular disease remains a leading cause of mortality in Diabetes mellitus (DM), where chronic hyperglycemia induces oxidative stress, mitochondrial dysfunction, and hypoxia in cardiomyocytes. Liraglutide (Lir), a glucagon-like peptide-1 receptor agonist, is widely used for type 2 DM management and has been shown to exert cardioprotective and antioxidant effects. This study aimed to evaluate whether Lir mitigates hyperglycemia-induced oxidative and hypoxic stress in H9c2 cardiomyoblasts while preserving cellular ultrastructure. Materials and Methods: H9c2 cells were cultured under normoglycemic (5.5 mM) or hyperglycemic (30 mM) conditions, with or without Lir. Cell viability was assessed using MTT assay. Ultrastructural changes were examined by transmission electron microscopy (TEM). Hypoxia-inducible factor-1α (HIF-1α), lipid peroxidation markers (LOOH, MDA), advanced oxidation protein products (AOPP), and total antioxidant capacity (TAC) were quantified by spectrophotometric assays. Results: MTT assays revealed that Lir significantly improved cell viability under hyperglycemic conditions and the EC50 was 1.05 ± 0.06 μM after 48 h of treatment. Under HG, HIF-1α, lipid hydroperoxides (LOOH), malondialdehyde (MDA) and advanced oxidation protein products (AOPP) increased and total antioxidant capacity (TAC) decreased (p < 0.001, for all); Lir significantly reversed these changes, restoring values to near-NG levels. Ultrastructural analysis of HG + Lir-treated cells revealed reduced granules, increased vacuolization, and slight rough endoplasmic reticulum dilatation, though mitochondria appeared normal. Conclusions: Lir significantly attenuated oxidative stress and cellular injury in cardiomyocytes under hyperglycemic conditions, improving viability, modulating HIF-1α expression, and restoring antioxidant balance. These findings support a dual role for Lir in diabetic cardiomyopathy: glucose-independent cytoprotection and regulation of mitochondrial and hypoxia pathways, highlighting its therapeutic potential beyond glycemic control.

  • Open Access

    Comparison of Drug Delivery Systems with Different Types of Nanoparticles in Terms of Cellular Uptake and Responses in Human Endothelial Cells, Pericytes, and Astrocytes

    by Hakan Sahin, Oguz Yucel, Paul Holloway, Eren Yildirim, Serkan Emik, Gulten Gurdag, Gamze Tanriverdi, Gozde Erkanli Senturk

    Background/Objectives: The key components of the blood–brain barrier (BBB) are endothelial cells, pericytes, astrocytes, and the capillary basement membrane. The BBB serves as the main barrier for drug delivery to the brain and is the most restrictive endothelial barrier in the body. Nearly all large therapeutic molecules and over 90% of small-molecule drugs cannot cross the BBB. To overcome this challenge, nanotechnology, particularly drug delivery systems such as nanoparticles (NPs), have gained significant attention. Methods: Poly(lactide-co-glycolide) (PLGA) and albumin-based NPs (bovine/human), with or without transferrin (Tf) ligands (BSA, HSA, BSA-Tf, HSA-Tf), and nanolipid carriers (NLC) were synthesized. The interactions of these NPs with human brain microvascular endothelial cells (hBMECs), human brain vascular pericytes (hBVPs), and human astrocytes (hASTROs) were analyzed. Results: At doses of 15.62 µg/mL, 31.25 µg/mL, and 62.5 µg/mL, none of the NPs caused toxic effects on hBMECs, hBVPs, or hASTROs after 3 h of incubation. All NPs were internalized by the cells, but BSA-Tf and HSA-Tf showed significantly higher uptake in hBMECs in a dose-dependent manner. Ultrastructural analysis revealed notable differences between NP formulation and cell type. Conclusions: Our findings underscore the potential of ligand-targeted NPs to selectively interact with BBB endothelial cells. Ultrastructural analysis reveals distinct cellular processing pathways for various NP formulations across BBB-associated cell types, with autophagy emerging as a crucial mechanism for NP handling in pericytes and astrocytes. Changes in NP chemical properties upon biological exposure present significant challenges for nanomedicine design, emphasizing the need for further investigation into NP interactions at the cellular and subcellular levels.


  • Myrtle improves renovascular hypertension-induced oxidative damage in heart, kidney, and aortic tissue

    by Sule Arslan, Ozan Ozcan, Begüm Gurel-Gokmen, Zatiye Ayça Cevikelli-Yakut, Halil Ibrahim Saygı, Ali Sen, Fatih Göger, Gözde Erkanli-Senturk, Goksel Sener, Tugba Tunali-Akbay